Second-trimester maternal pregnancy-associated plasma protein A and inhibin A levels in fetal trisomies

Fetal Diagnosis and Therapy

Volumn 17, Issue 3, 2002, Pages 137-141

  Watanabe, Hideki ^a   Hamada, Hiromi ^a   Yamada, Naoki ^a   Ogura, Tsuyoshi ^a   Yasuoka, Mana Obata ^a   Okuno, Suzuka ^a   Fujiki, Yutaka ^a   Sohda, Satoshi ^a   Kubo, Takeshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Fetal trisomy; Inhibin A; Pregnancy associated plasma protein A; Second trimester

Indexed keywords

INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TRISOMY;

EID: 0036206610     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048026     Document Type: Article

References (40)

1. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening
2. Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome
3. Second-trimester maternal serum analyte levels associated with fetal trisomy 13
4. Antigenic constituents in pregnancy plasma which are undetectable in normal non-pregnant female or male plasma
5. Human pregnancy-associated plasma proteins during the postpartum period
6. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein
7. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
8. First trimester biochemical screening for Down's syndrome
9. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome
10. Pregnancy-associated plasma protein A (PAPP-A): Measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies
11. Appropriate biochemical parameters in first-trimester screening for Down syndrome
12. Maternal serum screening for Down syndrome in the first trimester: Experience from Belarus
13. First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy: The combined test
14. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG
15. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks
16. First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies
17. A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): A possible first trimester method of screening for Down syndrome and other trisomies
18. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy
19. Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy
20. Screening for Down's syndrome: Changes in marker levels and detection rates between first and second trimesters
21. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific beta1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18
22. The transforming growth factor-beta family
23. Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone
24. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome
25. Measurement of circulating inhibin forms during the establishment of pregnancy
26. Second-trimester dimeric inhibin-A in Down's syndrome screening
27. The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy
28. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy
29. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A
30. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies
31. Prenatal screening for Down's syndrome using inhibin-A as a serum marker
32. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome
33. One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
34. Pregnancy associated plasma protein A in Down's syndrome
35. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18
36. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops
37. Inhibin A and non-Down syndrome aneuploidy
38. Elevated levels of maternal plasma alpha-fetoprotein after amniocentesis
39. Fetal-maternal bleeding associated with genetic amniocentesis
40. Feto-maternal haemorrhage associated with genetic amniocentesis: Results of a randomized trial